A
Anjali S. Kumar
Researcher at Washington State University Spokane
Publications - 30
Citations - 1559
Anjali S. Kumar is an academic researcher from Washington State University Spokane. The author has contributed to research in topics: Microsurgery & Colorectal surgery. The author has an hindex of 12, co-authored 30 publications receiving 1282 citations. Previous affiliations of Anjali S. Kumar include MedStar Washington Hospital Center & Washington State University.
Papers
More filters
Journal ArticleDOI
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
Julio Garcia-Aguilar,Oliver S. Chow,David D. Smith,Jorge E. Marcet,Peter A. Cataldo,Madhulika G. Varma,Anjali S. Kumar,Samuel Oommen,Theodore Coutsoftides,Steven R. Hunt,Michael J. Stamos,Charles A. Ternent,Daniel O. Herzig,Alessandro Fichera,Blase N. Polite,David W. Dietz,Sujata Patil,Karin Avila +17 more
TL;DR: Delivery of mFOLFOX6 after chemoradiation and before total mesorectal excision has the potential to increase the proportion of patients eligible for less invasive treatment strategies; this strategy is being tested in phase 3 clinical trials.
Journal ArticleDOI
Breast Cancer Growth Prevention by Statins
Michael J. Campbell,Laura J. Esserman,Yamei Zhou,Mark Shoemaker,Margaret Lobo,Elizabeth Borman,Frederick L. Baehner,Anjali S. Kumar,Kelly Adduci,Corina Marx,Emanuel F. Petricoin,Lance A. Liotta,Mary Winters,Stephen C. Benz,Christopher C. Benz +14 more
TL;DR: In vivo results showed that oral dosing of statins significantly inhibited the growth of a mouse mammary carcinoma, and supporting rationale for future statin trials in breast cancer patients is provided.
Journal ArticleDOI
Optimizing the total skin-sparing mastectomy.
TL;DR: Total skin-sparing mastectomy is a viable surgical option in selected patients with breast neoplasm and those who choose prophylactic mastectomy, and may increase the willingness of women to consider mastectomy to reduce their risk of breast cancer.
Journal ArticleDOI
Biologic versus Synthetic Mesh Reinforcement: What are the Pros and Cons?
TL;DR: This review will outline the properties of commonly used materials, highlighting the strength and weakness of each, and discuss recommendations regarding mesh selection, coding, and reimbursement.
Journal ArticleDOI
Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: Final results of a multicenter phase II trial
Michael R. Marco,Lihong Zhou,Sujata Patil,Jorge E. Marcet,Madhulika G. Varma,Samuel Oommen,Peter A. Cataldo,Steven R. Hunt,Anjali S. Kumar,Daniel O. Herzig,Alessandro Fichera,Blase N. Polite,Neil Hyman,Charles A. Ternent,Michael J. Stamos,Alessio Pigazzi,David W. Dietz,Yuliya Yakunina,Raphael Pelossof,Julio Garcia-Aguilar +19 more
TL;DR: Adding modified FOLFOX6 after chemoradiotherapy and before total mesorectal excision increases compliance with systemic chemotherapy and disease-free survival in patients with locally advanced rectal cancer.